NUCALA is the first approved
treatment to specifically target eosinophils, a source of inflammation in nasal polyps

Find your NuNormal with NUCALA

NUCALA is the first approved
treatment to specifically target eosinophils, a source of inflammation in nasal polyps.

Find your NuNormal with NUCALA

NUCALA is a prescription medicine for add-on maintenance treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adults whose disease is not controlled with nasal corticosteroids.

NUCALA is a non-surgical treatment for nasal polyps

When you have nasal polyps, there is inflammation in your nasal passages. Eosinophils [ee-uh-sin-uh-fils], a type of white blood cell, play an important role in this inflammation. NUCALA is the first medicine approved by the FDA to specifically target eosinophils in patients with nasal polyps.


NUCALA was proven to reduce:*†

nose-icon

Size of nasal polyps

icon

Nasal congestion

repeat-surgery-icon

Need for repeat surgery

*Added to current nasal polyp medication.
In a clinical study, compared to those not taking NUCALA.

Ask your doctor about NUCALA today

nucala-autoinjector

The NUCALA Autoinjector

Curious about taking your medication at home? See your options.

Learn about the Autoinjector

Questions about financial assistance and support?

Help is available along the way with nurse support and, for eligible patients, financial assistance.

Learn about eligibility

Before you start taking NUCALA

There is important information you need to know before you begin treating your nasal polyps with NUCALA.

Read Risks & Side Effects